Skip to content

The impact of norepinephrine on the dynamic aspect of brain activity

The impact of norepinephrine on the dynamic aspect of brain activity - Dyn-Neuromod

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49449
Enrollment
36
Registered
2020-08-10
Start date
2021-10-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scientific investigation of healthy subjects healthy

Interventions

None listed

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy adult subjects with no history of neurological disorder/disease and no counter-indications to 3 Tesla MRI or to atomoxetine, and no personal relationship with the researchers will be included in this study. All participants will be right-handed with normal vision or contact lenses.

Exclusion criteria

Exclusion criteria: Significant history of head trauma, premature birth, learning disabilities, neurological or psychiatric illness. Heart arrhythmia, glaucoma, congenital eye diseases, hyperopia, myopia, hypertension and use of anti-depressants or psychotropic medication and possible pregnancy (in adult females). MRI contra-indications, including metal implants and claustrophobia. Smoking more than five cigarettes a day - to avoid nicotine withdrawal effects during the study. Alcohol consumption

Design outcomes

Primary

MeasureTime frame
* Behavioural measures: effect of atomoxetine on accuracy and reaction time. * Brain activity measures: effect of atomoxetine on task-related evoked BOLD signal, measures of information flow, and correlation measures between BOLD time courses in regions of interest. * Computational measures: model fit to empirical fMRI data under different levels of atomoxetine.

Secondary

MeasureTime frame
* Psychometric measures: state anxiety, trait anxiety, emotional arousal, as regressors for behavioural and fMRI data. * Psychophysiological measures: task-related and task-unrelated changes in pupil size, as regressors for behavioural and fMRI data.. * Physiological measures: salivary cortisol and alpha amylase, as regressor for behavioural and fMRI data.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)